NuGen Medical Devices Inc. (TSXV:NGMD)
Canada flag Canada · Delayed Price · Currency is CAD
0.0300
0.00 (0.00%)
At close: Feb 6, 2026

NuGen Medical Devices Income Statement

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
0.591.010.330.150.140.05
Revenue Growth (YoY)
-22.73%204.73%117.52%10.69%191.04%-
Cost of Revenue
0.270.490.170.050.050.01
Gross Profit
0.320.520.160.10.090.03
Selling, General & Admin
3.575.037.524.245.262.26
Operating Expenses
4.225.688.214.895.882.62
Operating Income
-3.9-5.16-8.05-4.79-5.79-2.59
Interest Expense
-2.89-1.67-1.24-1.01-1.21-0.42
Interest & Investment Income
-----0.02
Currency Exchange Gain (Loss)
-0.11-0.11-0.11-0.10.3-0.16
Other Non Operating Income (Expenses)
3.160.040.020.06-1.11-0.23
EBT Excluding Unusual Items
-3.74-6.89-9.38-5.84-7.81-3.38
Asset Writedown
-----0.16-0.02
Other Unusual Items
1.631.670.050.270.87-0.26
Pretax Income
-2.12-5.22-9.33-5.57-7.1-3.66
Income Tax Expense
-00.010.03000.01
Net Income
-2.12-5.23-9.36-5.58-7.11-3.67
Net Income to Common
-2.12-5.23-9.36-5.58-7.11-3.67
Shares Outstanding (Basic)
225214168906954
Shares Outstanding (Diluted)
225214168906954
Shares Change (YoY)
7.48%27.89%86.08%31.20%26.95%128.66%
EPS (Basic)
-0.01-0.02-0.06-0.06-0.10-0.07
EPS (Diluted)
-0.01-0.02-0.06-0.06-0.10-0.07
Free Cash Flow
-5.51-4.72-6.72-2.13-4.1-1.4
Free Cash Flow Per Share
-0.03-0.02-0.04-0.02-0.06-0.03
Gross Margin
54.97%51.68%49.74%65.09%67.00%72.70%
Operating Margin
-660.85%-510.70%-2428.48%-3146.56%-4207.91%-5475.96%
Profit Margin
-359.36%-517.47%-2825.03%-3661.07%-5163.23%-7760.65%
Free Cash Flow Margin
-935.58%-467.79%-2026.89%-1399.36%-2977.84%-2958.59%
EBITDA
-3.25-4.54-7.44-4.22-5.17-2.22
D&A For EBITDA
0.640.620.610.580.630.37
EBIT
-3.9-5.16-8.05-4.79-5.79-2.59
Source: S&P Global Market Intelligence. Standard template. Financial Sources.